Please use this identifier to cite or link to this item: https://doi.org/10.1128/mBio.00253-15
DC FieldValue
dc.titleTarget mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria
dc.contributor.authorMoreira W.
dc.contributor.authorNgan G.J.Y.
dc.contributor.authorLow J.L.
dc.contributor.authorPoulsen A.
dc.contributor.authorChia B.C.S.
dc.contributor.authorAng M.J.Y.
dc.contributor.authorYap A.
dc.contributor.authorFulwood J.
dc.contributor.authorLakshmanan U.
dc.contributor.authorLim J.
dc.contributor.authorKhoo A.Y.T.
dc.contributor.authorFlotow H.
dc.contributor.authorHill J.
dc.contributor.authorRaju R.M.
dc.contributor.authorRubin E.J.
dc.contributor.authorDick T.
dc.date.accessioned2018-08-17T08:47:49Z
dc.date.available2018-08-17T08:47:49Z
dc.date.issued2015
dc.identifier.citationMoreira W., Ngan G.J.Y., Low J.L., Poulsen A., Chia B.C.S., Ang M.J.Y., Yap A., Fulwood J., Lakshmanan U., Lim J., Khoo A.Y.T., Flotow H., Hill J., Raju R.M., Rubin E.J., Dick T. (2015). Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria. mBio 6 (3) : 1-13. ScholarBank@NUS Repository. https://doi.org/10.1128/mBio.00253-15
dc.identifier.issn21612129
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/145963
dc.publisherAmerican Society for Microbiology
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentMEDICINE
dc.contributor.departmentCHEMISTRY
dc.contributor.departmentSURGERY
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.description.doi10.1128/mBio.00253-15
dc.description.sourcetitlemBio
dc.description.volume6
dc.description.issue3
dc.description.page1-13
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
mBio.00253-15.pdf2.31 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.